Taiwan study maps HER2 in Hard-to-Treat gynecologic cancers
NCT ID NCT06925113
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This study reviewed medical records of 509 adults in Taiwan with advanced endometrial, ovarian, or cervical cancer. Researchers wanted to find out how many of these cancers have high levels of a protein called HER2 (IHC 3+). This information could help doctors identify patients who might benefit from a targeted therapy already approved for other HER2-positive cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 833, Taiwan
-
Mackay Memorial Hospital
Taipei, 104, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Taichung Veterans General Hospital
Taichung, 407, Taiwan
-
Taipei Veterans General Hospital
Taipei, 112, Taiwan
Conditions
Explore the condition pages connected to this study.